ezetimibe has been researched along with rizatriptan in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (rizatriptan) | Trials (rizatriptan) | Recent Studies (post-2010) (rizatriptan) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 349 | 106 | 75 |
| Protein | Taxonomy | ezetimibe (IC50) | rizatriptan (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.3572 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 6.3096 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.0452 | |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 0.041 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 7.9433 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 7.9433 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 3.9811 | |
| 5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 0.0501 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 3.9811 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for ezetimibe and rizatriptan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |